FDA Just Voted on BPC-157, Semax & 5 Others — 6 Passed, 1 Rejected
Hearings & news coverage — FDA Just Voted on BPC-157, Semax & 5 Others — 6 Passed, 1 Rejected
Channel: LeAnn LeFortune · Our label: Hearing coverage and news reporting · Source: youtube.com/watch?v=pa7zNpdZuoU
What this video covers
Over two days, an FDA advisory panel just heard more than 18 hours of testimony on seven peptides you’ve probably heard of. And the reason it didn’t is more interesting than you’d think. I have a biology degree, former field researcher for Alaska Fish and Game, and now I spend my time in the peptide research space instead of the Alaskan wilderness. I follow this regulatory stuff closely because it actually matters for anyone paying attention to this space.
Summary drawn from this video’s own transcript (banked in our research library, pulled 2026-11-07). Claims below are the speaker’s — attributed, not endorsed. This site publishes no dosing, protocol, or sourcing information.
Key points, in the speaker’s own framing
- Over two days, an FDA advisory panel just heard more than 18 hours of testimony on seven peptides you’ve probably heard of.
- It was the FDA Pharmacy Compounding Advisory Committee, or PCAC for short, deciding whether seven peptides should be added to something called the 503A bulks list.
- That’s a list that lets a licensed compounding pharmacy legally prepare a substance with a doctor’s prescription.
- They were BPC-157, KPV, TB-500, and MOTS-c on day one.
- BPC-157, KPV, and TB-500 each passed eight to six with one abstention.
- FDA’s own scientists had actually recommended against all seven peptides going in, citing insufficient safety and effectiveness evidence across the board.
Read next
- BPC-157 — compound page
- TB-500 — compound page
- MOTS-c — compound page
- Epitalon — compound page
- Semax — compound page
- KPV — compound page
- DSIP — more videos
- All videos from this channel
Educational information only — not medical advice. Peptides discussed on this page include substances that are not FDA-approved.